NewAmsterdam Pharma Stock Forecast - Triple Exponential Smoothing

NAMS Stock   19.85  0.95  4.57%   
The Triple Exponential Smoothing forecasted value of NewAmsterdam Pharma on the next trading day is expected to be 19.80 with a mean absolute deviation of 0.54 and the sum of the absolute errors of 32.12. NewAmsterdam Stock Forecast is based on your current time horizon.
  
Receivables Turnover is likely to drop to 37.06 in 2024. Fixed Asset Turnover is likely to drop to 120.05 in 2024. Common Stock Shares Outstanding is likely to gain to about 86.3 M in 2024, whereas Net Loss is likely to drop (27 M) in 2024.
Triple exponential smoothing for NewAmsterdam Pharma - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When NewAmsterdam Pharma prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in NewAmsterdam Pharma price movement. However, neither of these exponential smoothing models address any seasonality of NewAmsterdam Pharma.

NewAmsterdam Pharma Triple Exponential Smoothing Price Forecast For the 30th of November

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of NewAmsterdam Pharma on the next trading day is expected to be 19.80 with a mean absolute deviation of 0.54, mean absolute percentage error of 0.63, and the sum of the absolute errors of 32.12.
Please note that although there have been many attempts to predict NewAmsterdam Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that NewAmsterdam Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

NewAmsterdam Pharma Stock Forecast Pattern

Backtest NewAmsterdam PharmaNewAmsterdam Pharma Price PredictionBuy or Sell Advice 

NewAmsterdam Pharma Forecasted Value

In the context of forecasting NewAmsterdam Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. NewAmsterdam Pharma's downside and upside margins for the forecasting period are 16.17 and 23.43, respectively. We have considered NewAmsterdam Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
19.85
19.80
Expected Value
23.43
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of NewAmsterdam Pharma stock data series using in forecasting. Note that when a statistical model is used to represent NewAmsterdam Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.0393
MADMean absolute deviation0.5444
MAPEMean absolute percentage error0.0282
SAESum of the absolute errors32.1212
As with simple exponential smoothing, in triple exponential smoothing models past NewAmsterdam Pharma observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older NewAmsterdam Pharma observations.

Predictive Modules for NewAmsterdam Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NewAmsterdam Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
17.5521.1524.75
Details
Intrinsic
Valuation
LowRealHigh
19.2522.8526.45
Details
9 Analysts
Consensus
LowTargetHigh
22.9025.1627.93
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.63-0.54-0.46
Details

Other Forecasting Options for NewAmsterdam Pharma

For every potential investor in NewAmsterdam, whether a beginner or expert, NewAmsterdam Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. NewAmsterdam Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in NewAmsterdam. Basic forecasting techniques help filter out the noise by identifying NewAmsterdam Pharma's price trends.

NewAmsterdam Pharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NewAmsterdam Pharma stock to make a market-neutral strategy. Peer analysis of NewAmsterdam Pharma could also be used in its relative valuation, which is a method of valuing NewAmsterdam Pharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

NewAmsterdam Pharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of NewAmsterdam Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of NewAmsterdam Pharma's current price.

NewAmsterdam Pharma Market Strength Events

Market strength indicators help investors to evaluate how NewAmsterdam Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NewAmsterdam Pharma shares will generate the highest return on investment. By undertsting and applying NewAmsterdam Pharma stock market strength indicators, traders can identify NewAmsterdam Pharma entry and exit signals to maximize returns.

NewAmsterdam Pharma Risk Indicators

The analysis of NewAmsterdam Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NewAmsterdam Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting newamsterdam stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NewAmsterdam Stock Analysis

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.